Nutraceuticals: Beyond the diet before the drugs

Current Bioactive Compounds

Volumn 10, Issue 1, 2014, Pages 1-12

  Santini, Antonello ^a   Novellino, Ettore ^a  

^a Department of Pharmacy ^*  (Italy)

Author keywords

Food; Health; Hypercholesterolemia; Metabolic syndrome; Nutraceuticals; Prevention; Therapy

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANTIOXIDANT; INSULIN; LOW DENSITY LIPOPROTEIN; NUTRACEUTICAL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; POLYPHENOL; POLYUNSATURATED FATTY ACID; PREBIOTIC AGENT; PROBIOTIC AGENT; TANNIN DERIVATIVE;

ARTICLE; CARDIOVASCULAR RISK; CONFORMATIONAL TRANSITION; DIETARY FIBER; DIETARY INTAKE; DYSLIPIDEMIA; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; FUNCTIONAL FOOD; HABIT; HEALTH CARE COST; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; TUNA; WATCHFUL WAITING;

EID: 84905676608     PISSN: 15734072     EISSN: 18756646     Source Type: Journal    
DOI: 10.2174/157340721001140724145924     Document Type: Article

References (59)

1. DeFelice, S.L. The Nutraceutical Revolution: Fueling a Powerful, New International Market, In: Harvard University Advanced Management Program in Biomedical Research and Development, 1989; Como, Italy.
2. Espín, J.C.; García-Conesa, M.T.; Tomás-Barberán F.A. Nutraceuticals: facts and fiction. Phytochemistry, 2007, 68, 2986-3008.
3. Colonna, S.; Fulk, G.; Marangoni, F. The food for the health. In: The health foods. Springer Ed.; Milan, Italy, 2013, 211-220.
4. Cox, W.; Guyer, D. Getting well: four basic principles for getting well. Authorhouse: Bloomington, IN, United States, 2004.
5. Vigna, G.B.; Fellin, R. Pharmacotherapy of dyslipidemias in the adult population. Expert opinions on Pharmacotherapy, 2010, 11, 3041-3052.
6. Ross, S. Functional foods: the Food and Drug Administration perspective. Am. J. Clin. Nut., 2000, 71, 1735-1738.
7. Bergamini, E. Nutraceuticals: a valuable asset to be used carefully. G. Gerontol., 2010, 58, 255-258.
8. Borghi, C.; Cicero, A.F.G. Nutraceuticals and functional foods in preventive medicine, Bononia University Press, Italy, 2011.
9. Santini, A. Nutraceuticals: An Healthy Bet for the Future, Journal of Food Research, 2014, 3, 1-2.
10. World Health Organization (WHO), Act No. 93, 1947.
11. Schwartz Cowan, R. The Industrial Revolution in the Home: Household Technology and Social Change in the 20th Century. Technology and Culture, 1976, 17, 1-23.
12. Caplan, P. Food, health and Identity, Routledge, London, United Kingdom, 2013.
13. Wollstonecroft, M.A. Investigating the role of food processing in human evolution: a niche construction approach. Archaeol. Anthropol. Sci., 2011, 3, 141-150.
14. Cordain, L.; Eaton, S.B.; Sebastian, A.; Mann, N.; Lindeberg, S.; Watkins, B.A.; O'Keefe, J.H.; Brand-Miller, J. Origins and evolution of the Western diet: health implications for the 21st century. The American journal of clinical nutrition, 2005, 81, 341-354.
15. Ferriman, A. BMJ readers choose the "sanitary revolution" as greatest medical advance since 1840. BMJ, 2007, 334(7585), 111.
16. WHO, 2013, http://apps.who.int/gho/data/node.main.688?lang=en (Accessed June 23, 2014).
17. ISTAT, 2011, http://www.istat.it/it/salute-e-sanit%C3%A0 (Accessed June 23, 2014).
18. Pandey, M.; Verma, R.K.; Saraf, S.A. Nutraceuticals: new era of medicine and health. Asian J Pharm Clin Res., 2010, 3, 11-15.
19. Bernal, J.; Mendiola, J.; Ibáñez E.; Cifuentes, A. Advanced analysis of nutraceuticals. J Pharm. Biomed. Anal., 2010. 55,758-774.
20. Shahidi, F. Nutraceuticals and functional foods: whole versus processed foods. Trends Food Sci. Technol., 2009, 20, 376-387.
21. Espin, J.; García-Conesa, M.; Tomas-Barberan, F. Nutraceuticals: facts and fiction. Phytochemistry, 2007, 68, 2986-3008.
22. Lachance, P.; Das, Y. In: Nutraceuticals. Kennewell P., Editor. Comprehensive medicinal chemistry 2: global perspective. Oxford Elsevier Science Ltd, London, United Kingdom, 2007, 449-461.
23. Das, L.; Bhaumik, E.; Raychaudhuri, U.; Chakraborty, R. Role of nutraceuticals in human health. Journal of Food Science and Technol., 2012, 49, 173-183.
24. Biesalski, H.; Dragsted, L.; Elmadfa, I.; Grossklaus, R.; Müller, M.; Schrenk, D.; Walter, P.; Weber, P. Bioactive compounds: safety and efficacy. Nutrition, 2009, 25, 1206-1211.
25. Nair H, Sung B, Yadav V, Kannappan R, Chaturvedi M, Aggarwal B. 2010. Delivery of anti-inflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol., 2010, 80, 1833-1843.
26. Nobili, S.; Lippi, D.; Witort, E.; Donnini, M.; Bausi, L.; Mini, E.; Capaccioli, S. Natural compounds for cancer treatment and prevention. Pharmacol. Res., 2009, 59, 365-378.
27. Kaulmann, A.; Jonville, M.C.; Schneider, Y.J.; Hoffmann, L.; Bohn, T. Carotenoids, polyphenols and micronutrient profiles of Brassica oleaceae and plum varieties and their contribution to measures of total antioxidant capacity. Food Chem., 2014, 155, 240-250.
28. Maddi, V.S.; Aragade, P.D.; Digge, V.G.; Nitaliker, M.N. Importance of nutraceuticals in health management. Pharmacognosy Rev., 2007, 1, 377-379.
29. Rishi, R.K. Nutraceuticals: borderline between food and drug? Pharma Rev., 2006, 2, 51-53.
30. Adelaja, A.O.; Schilling, B.J. Nutraceutical: blurring the line between food and drugs in the twenty-first century. Mag. Food Farm. Resour. Issues, 1999, 14, 35-40.
31. Afilalo, J.; Duque, G.; Steele, R.; Jukema, J.W.; de Craen, A.J.; Eisenberg, M.J. Statins for secondary prevention in elderly patients. J. Am. Coll. Cardiol., 2008, 51, 37-45.
32. Cicero, A.F.G.; Rovati, L.; Setnikar, I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents in humans. Arzneimittelforschung, 2007, 57, 26-30.
33. Kong, W.; Wei, J.; Abidi, P.; Lin, M.; Inaba, S.; Li, C.; Wang, Y.; Si, S.; Pan, H.; Wang, S.; Wu, J.; Wang, Y.; Li, Z.; Liu, J.; Jiang, J.D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Med., 2004, 10, 1344-1351.
34. Albert, C.M.; Campos, H.; Stampfer, M.J.; Ridker, P.M.; Manson, J.E.; Willett, W.C.; Ma, J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. New Engl. J. Med., 2002, 346, 1113-1118.
35. Brusq, J.M.; Ancellin, N.; Grondin, P.; Guillard, R.; Martin, S.; Saintillan, Y.; Issandou, M. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J. Lipid Res., 2006, 47, 1281-1288.
36. Marazzi, M.; Cacciotti, L.; Pelliccia, F.; Iaia, L.; Volterrani, M.; Caminiti, G.; Sposato, B.; Massaro, R.; Grieco, F.; Rosano, G. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Advances in Therapy, 2011, 28, 1105-1113.
37. Cicero, A.F.; Tartagni, E.; Ertek, S. Nutraceuticals for metabolic syndrome management: from laboratory to benchside. Curr. Vasc. Pharmacol., 2013, 11, 1-7.
38. G.H. of S. (1866, Feb 24). Singing bread. Notes and Queries Magazine, 1866, 3(9), 153.
39. Briggs, A.D.M. A statin a day keeps the doctor away: comparative proverb assessment modelling study. BMJ, 2013, 347:f7267.
40. Briggs, A.D.M. http://www.bmj.com/pressreleases/2013/12/17/apple-day-keeps-doctor-away (Accessed June 23, 2014).
41. Tenore, G.C.; Campiglia, P.; Stiuso, P.; Ritieni, A.; Novellino, E. Nutraceutical potential of polyphenolic fractions from Annurca apple (M. pumila Miller cv Annurca). Food Chem., 2013, 140, 614-622.
42. Ghosh, R.K.; Ghosh, S.M.; Chawla, S.; Jasdanwala, S.A. SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus. The Journal of Clinical Pharmacology, 2012, 4, 457-463.
43. Larrosa, M.; González-Sarrías, A.; Yáñez-Gascón, M.J.; Selma, M.V.; Azorín-Ortuño, M.; Toti, S.; Tomás-Barberán, F.; Dolara, P.; Espín, J.C. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem., 2010, 21, 717-725.
44. Yahia, E.M. The contribution of fruits and vegetables consumption to human health. In: Fruit and vegetable phytochemicals: chemistry, nutritional and stability; de la RosaLA, Alvarez-Parrilla E, Gonzalez-Aguilar GA, Editors. Wiley-Blackwell, London, United Kingdom 2010, pp. 3-52.
45. Mandel, S.; Packer, L.; Youdim, M.; Weinreb, O. Proceedings from the "Third International Conference on Mechanism of Action of Nutraceuticals". J. Nutr. Biochem., 2005, 16, 513-20.
46. Harris, W.S. The omega-3 index: from biomarker to risk marker to risk factor. Curr. Atheroscler. Rep., 2009, 11, 411-417.
47. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 2002, 106, 2747-2757.
48. Arterburn, L.M.; Hall, E.B.; Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin Nutr., 2006, 83, 1467S-1476S.
49. Mozaffarian, D.; Lemaitre, R.N.; Kuller, L.H.; Burke, G.L.; Tracy, R.P.; Siscovick, D.S. Cardiovascular Health Study Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003, 107, 1372-1377.
50. Shirode, C.S.; Mundada, A.R.; Kadam, A.S. Nutraceuticals - An Emerging Era in the Treatment and Prevention of Cardiovascular Diseases. Current Pharmaceutical Biotechnology, 2009, 7, 15-23.
51. Tavani, A.; Pelucchi, C.; Parpinel, M.; Negri, E.; Franceschi, S.; Levi, F.; La Vecchia, C. N-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland. Int. J. Cancer, 2003, 105, 113-116.
52. Itoh, T.; Yamamoto, K. Peroxisome proliferator activated receptor and oxidized docosahexaenoic acids as new class of ligand. Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377, 541-547.
53. Garelnabi, M.; Selvarajan, K.; Litvinov, D.; Santanam, N.; Parthasarathy, S. Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms. Atherosclerosis, 2008, 199, 304-309.
54. Kita, T.; Arai, H. Oxidized fatty acid and PPAR-gamma. Nippon Rinsho, 2001, 59, 823-830.
55. Eliminate, T.; Itoh, T.; Fairall, L.; K. Amin, K.; Yuka Inaba, Y.; Szanto, A.; Balint, L.; Laszlo, N.; Keiko Yamamoto, K.; Schwabe, J.W.R. Structural basis for the activation of PPAR by oxidized fatty acids. Nature Structural and Molecular Biology, 2008, 15, 924-931.
56. Xu, H.E.; Lambert, M.H.; Montana, V.G.; Parks, J.D.; Blanchard, S.G.; Brown, P.J.; Sternbach, D.D.; Lehmann, J.M.; Wisely, G.B.; Willson, T.M.; Kliewer, S.A.; Milburn, M.V. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Molecular Cell, 1999, 3, 397-403.
57. Gulati, O.P.; Ottawayb, P.B. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products. Toxicology, 2006, 221, 75-87.
58. Bagchi, D. Nutraceuticals and functional foods regulations in the United States and around the world. Volume in Food Science and Technology, Bagchi D. Ed.; Academic Press Elsevier Science B. V: Amsterdam, 2008.
59. Tenore, GC.; Calabrese, G.; Ritieni, A.; Campiglia, P.; Giannetti, D.; Novellino, E. Canned bluefin tuna, an in vitro cardioprotective functional food potentially safer than commercial fish oil based pharmaceutical formulations. Food and chemical toxycology, 2014, 231-235.